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The ends of chromosomes in mammals, called telomeres, are composed of a 6-bp repeat
sequence, TTAGGG, which is added on by the enzyme telomerase. In combination with a
protein complex called shelterin, these telomeric repeat sequences form a cap that pro-
tects the ends of chromosomes. Due to insufﬁcient telomerase expression, telomeres
shorten gradually with each cell division in human somatic cells, which limits the number
of times they can divide. The extensive cell division involved in cancer cell progression
therefore requires that cancer cells must acquire the ability to maintain telomeres, either
through expression of telomerase, or through an alternative mechanism involving recom-
bination. It is commonly thought that the source of many chromosome rearrangements
in cancer cells is a result of the extensive telomere shortening that occurs prior to the
expression of telomerase. However, despite the expression of telomerase, tumor cells
can continue to show chromosome instability due to telomere loss. Dysfunctional telom-
eres in cancer cells can result from oncogene-induced replication stress, which results
in double-strand breaks (DSBs) at fragile sites, including telomeres. DSBs near telom-
eres are especially prone to chromosome rearrangements, because telomeric regions are
deﬁcient in DSB repair. The deﬁciency in DSB repair near telomeres is also an important
mechanism for ionizing radiation-induced replicative senescence in normal human cells.
In addition, DSBs near telomeres can result in chromosome instability in mouse embry-
onic stem cells, suggesting that telomere loss can contribute to heritable chromosome
rearrangements. Consistent with this possibility, telomeric regions in humans are highly
heterogeneous, and chromosome rearrangements near telomeres are commonly involved
in human genetic disease. Understanding the mechanisms of telomere loss will therefore
provide important insights into both human cancer and genetic disease.
Keywords: telomere, gross chromosomal rearrangement, sister chromatid fusion, chromosome instability, double-
strand break repair
TELOMERES
The genomes of eukaryotes are composed of linear DNA, which
requires a mechanism to protect chromosome ends from being
detected as DNA double-strand breaks (DSBs). The ends of linear
chromosomes in eukaryotes therefore contain caps, called telom-
eres, that distinguish natural chromosome ends fromDSBs (Black-
burn et al., 2006). Telomeres prevent chromosome ends from
activating DNA damage checkpoints and DSB repair pathways,
and thereby prevent the degradation and fusion of chromosome
ends. Mammalian telomeric DNA is composed of the TTAGGG
repeat sequence with a short single-stranded 3′ overhang at its
end. The single-stranded 3′ overhang is tucked back into a proxi-
mal complementary telomeric sequence to form the t-loop, which
essentially hides and protects the free end (Grifﬁth et al., 1999).
A telomere-speciﬁc six-subunit protein complex called shelterin
(TRF1, TRF2, RAP1, TIN2, TPP1, and POT1) plays a pivotal
role in the protection of chromosome ends (Palm and de Lange,
2008), as well as facilitating telomere replication and the addition
of telomeric repeat sequences. TRF1 and TRF2 bind speciﬁcally
to double-stranded telomeric repeat sequences and recruit the
other shelterin proteins and a variety of additional proteins to
the telomeres. TRF2 protects chromosome ends by regulating the
formation of the single-stranded 3′ overhang, while POT1, which
binds speciﬁcally to the single-stranded 3′ overhang, facilitates end
protection by promoting the formation of the t-loop (Hockemeyer
et al., 2005). POT1 and its partner TPP1 are also important in the
recruitment of telomerase to the telomere (Colgin et al., 2003; Xin
et al., 2007). Telomerase is a reverse transcriptase that carries an
RNA template that aligns with the end of the existing telomere to
add additional telomeric repeat sequences (Blackburn et al., 2006).
The regulation of access of telomerase to the telomere determines
telomere length, which ranges from 2 to 20 kb on different human
chromosomes (Lansdorp et al., 1996).
THE MECHANISM OF TELOMERE SHORTENING
DURING CELL DIVISION
Although telomeres are actively maintained in human germ line
cells and embryonic stem cells through the expression of telom-
erase, telomeres shorten when human somatic cells divide due
to insufﬁcient telomerase expression (Harley et al., 1990; Hastie
et al., 1990; Huffman et al., 2000). Approximately 50–200 bp of
telomeric repeat sequences are lost each time a mammalian cell
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divides. This telomere shortening results from a combination of a
failure to completely replicate the ends of linear DNA molecules,
termed the “end replication problem,” and the processing of DNA
that occurs on the ends of linear chromosomes.
During DNA replication, the end of the G-rich strand of the
telomere is synthesized by leading strand synthesis, and the ter-
minal of C-rich strand is replicated by lagging strand synthesis.
Following DNA replication, the end of the leading strand will be
blunt ended, and the 5′ end must therefore be resected to produce
the single-stranded 3′ overhang (Lingner et al., 1995). However,
the lagging strand is not completely replicated due to the presence
of the RNA primer, which does not start at the very end of the
chromosome (Olovnikov, 1973; Chow et al., 2012). As a result,
telomere shortening occurs with each round of DNA replication.
Telomere shortening also results from the processing of ends
of chromosomes following DNA replication, which is required
to form functional telomeres. The single-stranded 3′ overhang
is required for the association of the POT1/TPP1 complex and
t-loop formation, and is therefore necessary for telomere end pro-
tection. In addition, the single-stranded 3′ overhang is used as a
template for telomerase-mediated telomere elongation. Although
the lagging daughter strands synthesized during DNA replication
possess single-stranded 3′ overhangs at their ends soon after repli-
cation, the processing of the single-stranded 3′ overhang on the
ends of leading strands is not completed until late S/G2 phase
(Chow et al., 2012), consistent with the fact that telomeres are
recognized as DNA damage in the G2 phase of the cell cycle (Ver-
dun et al., 2005). The single-stranded 3′ overhang on the leading
strand is generated by resection of the 5′ end of the leading strand
by theApollo exonuclease, which is recruited to telomeres through
the interaction with TRF2 (Lam et al., 2010; Wu et al., 2010). The
inhibition of Apollo results in a reduction in single-stranded 3′
overhangs, the appearance of DNA damage signals at telomeres,
and chromatid fusions on the leading strand.
LikeApollo, EXO1 (Wu et al., 2010) andMRE11 (Larrivee et al.,
2004; Chai et al., 2006; Deng et al., 2009) also possesses nuclease
activity and contribute to themaintenance of the telomeric single-
stranded 3′ overhang in a TRF2-dependent manner. Determining
the exact role of MRE11 in maintaining single-stranded 3′ over-
hangs is complicated by the fact that MRE11 functions both as a
double-stranded3′ to 5′ exonuclease, and single-stranded endonu-
clease that acts on 5′ overhangs, 3′ ﬂaps, 3′ branches, and closed
hairpins (D’Amours and Jackson, 2002).
THE ROLE OF DSB REPAIR IN TELOMERE MAINTENANCE
AND CHROMOSOME FUSION
Understanding the mechanisms and consequences of the loss of
telomere function requires knowledge of DSB repair pathways,
both because DSB repair proteins are essential in telomere main-
tenance, and because dysfunctional telomeres are recognized as
DSBs. There are three DSB repair pathways, homologous recom-
bination repair (HRR; Moynahan and Jasin, 2010), classical non-
homologous end joining (C-NHEJ, also referred to as canonical
NHEJ; Lieber, 2010), and alternative NHEJ (A-NHEJ, also referred
to as microhomology-mediated end joining, deletional NHEJ, or
backup NHEJ; Nussenzweig and Nussenzweig, 2007; McVey and
Lee, 2008; Zha et al., 2009;Mladenov and Iliakis, 2011). The initial
steps in DSB recognition are similar for all three forms of DSB
repair. The DSB is ﬁrst recognized by the MRE11/RAD50/NBS1
(MRN) complex, leading to activation of ATM, which phospho-
rylates a large number of proteins involved in cell cycle regulation,
chromatin remodeling, and DNA repair (Lavin, 2007).
The major DSB repair pathway in mammalian cells is C-NHEJ,
which involves the direct joining of DNA ends using the proteins
KU70, KU86, DNA-PKcs, XRCC4, LIG4, and XLF (Lieber, 2010).
C-NHEJ can facilitate direct ligation with no processing of DSBs
generated by I-SceI endonuclease, although minimal processing
can be required to clean up ends at DSBs generated by ionizing
radiation or other means. HRR and A-NHEJ are actively sup-
pressed in the initial phase of DSB repair by ATM (Rahal et al.,
2008), which inhibits the resection of the DNA ends at the DSB
by phosphorylating KU70 and KU86 (Fattah et al., 2010; Langerak
et al., 2011; Sun et al., 2012), DNA-PKcs (Allen et al., 2003), 53BP1
(Cao et al., 2009; Bouwman et al., 2010; Bunting et al., 2010), the
MRN complex (Langerak et al., 2011; Sun et al., 2012), and his-
toneH2AX (Zha et al., 2010; Helmink et al., 2011). However, when
DSBs are not repaired by C-NHEJ in a timely manner (Rass et al.,
2009; Shibata et al., 2011), ATM then directs the processing of the
ends of DSBs by MRE11 and CtIP to generate a single-stranded
3′ overhang (Sartori et al., 2007). These single-stranded 3′ over-
hangs are then used for repair by either the HRR or A-NHEJ
pathways. For HRR, extensive resection is required by exonu-
clease EXO1 after processing by MRE11/CtIP (Steger et al., 2003;
Sun et al., 2012; Tomimatsu et al., 2012). The long single-stranded
3′ overhang generated by resection is then used to pair with the
homologous sequence in the sister chromatid, which then initiates
replication through the region containing theDSB (Moynahanand
Jasin, 2010). Error-free DSB repair with HRR is then completed
by the resolution of the crossover junctions generated between the
two sister chromatids. As a result of the requirement for the sister
chromatid as a template, HRR can only be used for DSB repair in
a limited portion of the cell cycle in which the region containing
the DSB has already been replicated, but before chromosomes are
condensed during mitosis. HRR involves a large number of pro-
teins, including RAD51 and BRCA2. MRE11, CtIP, and BRCA1
are involved in generating the single-stranded 3′ overhang, while
BRCA2 facilitates the binding of RAD51 to the single-stranded
3′ overhang, which mediates its pairing with its complementary
sequence on the sister chromatid (Moynahan and Jasin, 2010).
Like HRR, A-NHEJ also requires the processing of DSBs to
generate a single-stranded 3′ overhang for DSB repair. However,
unlike HRR, this processing by MRE11 can be either ATM depen-
dent or independent (Rass et al., 2009), and does not require
further resection, as shown by the lack of a requirement for
BRCA1 (Rass et al., 2009; Yun and Hiom, 2009). Moreover,
rather than using the single-stranded 3′ overhang for pairing
with the sister chromatid, A-NHEJ joins together sites within
two single-stranded 3′ overhangs, which is often facilitated by
microhomology (Guirouilh-Barbat et al., 2007; Yan et al., 2007;
Bennardo et al., 2008; Rass et al., 2009; Xie et al., 2009). The
requirement for the processing of DNA ends during A-NHEJ is
demonstrated by the fact that A-NHEJ is commonly associated
with deletions (Guirouilh-Barbat et al., 2004; Xie et al., 2009),
and is the primary repair mechanism involved in chromosome
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rearrangements (Zhu et al., 2002; Guirouilh-Barbat et al., 2007;
Weinstock et al., 2007; Zhang and Jasin, 2011). The pathway(s)
involved in A-NHEJ are not well deﬁned, although some of the
proteins that have been reported to be involved in A-NHEJ are
PARP, LIG3, XRCC1, MRE11, and CtIP ( Della-Maria et al., 2011;
Simsek et al., 2011; Zhang and Jasin, 2011).
In addition toDNA repair, NHEJ proteins play essential roles in
telomere function. KU70 protects chromosome ends fromhomol-
ogous recombination in mouse cells (Celli et al., 2006), while a
deﬁciency in KU86 in human cells is lethal due to its role in
suppressing HRR within telomeric repeat sequences (Wang et al.,
2009). DNA-PKcs is also important in regulating the resection
of the end of the leading strand following DNA replication, so
that DNA-PKcs deﬁciency results in an increase in chromosome
fusions that speciﬁcally involve the leading strand (Bailey et al.,
2001). HRR proteins have also been found to be involved in telom-
eremaintenance, including BRCA2, which facilitates RAD51 load-
ing for telomere replication and cap formation (Badie et al., 2010).
LOSS OF TELOMERE FUNCTION DUE TO A DEFICIENCY
IN SHELTERIN PROTEINS
The inability to properly form caps on the ends of chromosomes
has severe consequences for a cell even when telomeric repeat
sequences are still present. A deﬁciency in TRF2 in mammalian
cells results in extensive chromosome fusion and cell death due to
the inability to maintain the single-stranded 3′ overhang required
for t-loop formation (van Steensel et al., 1998). The chromosome
fusions resulting from TRF2 deﬁciency are dependent on ATM
(Karlseder et al., 2004), and occur through C-NHEJ, as shown
by the requirement for LIG4 for fusion to occur (Smogorzewska
et al., 2002). Chromosome fusions in TRF2-deﬁcient cells are
dependent upon the nuclease activity of MRE11, which medi-
ates the degradation of the telomeric single-stranded 3′ overhang,
demonstrating that TRF2 prevents chromosome fusions involv-
ing C-NHEJ by protecting the single-stranded 3′ overhang (Deng
et al., 2009). The high frequency of chromosome fusions in
TRF2-deﬁcient cells has made this a popular approach for inves-
tigating the mechanisms of chromosome fusion in mammalian
cells. However, although a deﬁciency in TRF2 provides valuable
insights into telomere structure and function, it is not represen-
tative of the mechanism of chromosome fusion involved in all
types of telomere dysfunction. Cells deﬁcient in POT1/TPP1 also
show an increase in chromosome fusions, although not to the
same extent as with TRF2 deﬁciency (Rai et al., 2010). However,
unlike with TRF2 deﬁciency, chromosome fusions in cells deﬁ-
cient in POT1/TPP1 are independent of the C-NHEJ proteins
53BP1 and LIG4, and therefore occur by A-NHEJ. Moreover, the
chromosome fusions with POT1/TPP1 are dependent on ATR,
not ATM (Denchi and de Lange, 2007; Guo et al., 2007; Deng
et al., 2009). This difference between the mechanisms of chro-
mosome fusion with deﬁciencies in TRF2 and POT1/TPP1 is
consistent with the structure of the chromosome ends resulting
from these deﬁciencies: the deﬁciency in TRF2 results in blunt
ends, which are conducive for C-NHEJ, while the deﬁciency in
POT1/TPP1 results in very long single-stranded 3′ overhangs
(Hockemeyer et al., 2006; Wu et al., 2006), which are conducive
for A-NHEJ.
Alternative NHEJ is also involved in chromosome fusions
resulting from naturally occurring telomere shortening in mice.
An initial study found that chromosome fusions occurring inmice
that are deﬁcient in the gene for the RNA template for telomerase,
mTERC, required KU86 and DNA-PKcs (Espejel et al., 2002).
However, subsequent studies with mTERC-deﬁcient mice found
that chromosome fusions occurred independently of LIG4, DNA-
PKcs (Maser et al., 2007), and 53BP1 (Rai et al., 2010), leading to
the conclusion that A-NHEJ is involved. Similarly, based on the
prevalence of microhomology at the sites of chromosome fusions,
A-NHEJ has been proposed as the primary mechanism responsi-
ble for chromosome fusions resulting from the loss of telomeric
repeat sequences in human cells, either by gradual telomere short-
ening (Capper et al., 2007) or stochastic mechanisms (Lo et al.,
2002b). The involvement of A-NHEJ suggests that chromosome
fusions resulting from the loss of telomeric repeat sequences is
commonly preceded by extensive resection, consistent with the
large deletions demonstrated by DNA sequence analysis of the
sites of chromosome fusion (Letsolo et al., 2010; Murnane, 2010).
THE CONSEQUENCES OF EXCESSIVE TELOMERE
SHORTENING IN NORMAL AND CANCER CELLS
The telomere shortening that occurs during cell division in human
somatic cells can eventually result in replicative cell senescence or
apoptosis if the telomeres become too short to protect the end
of the chromosome (Sharpless and DePinho, 2007). Studies with
human ﬁbroblasts have shown that senescence occurs when the
unprotected chromosome ends are recognized as DSBs (d’ Adda
di Fagagna et al., 2003; Herbig et al., 2004; Sedelnikova et al., 2004;
Zou et al., 2004), as shownby the presence of DSB repair complexes
that co-localize with telomeres, called telomere dysfunction-
induced foci (TIFs). The number of dysfunctional telomeres
required for senescence may vary between different cell types. In
ﬁbroblasts, ﬁve different dysfunctional telomeres are required for
senescence to occur (Kaul et al., 2012). The absence of chromo-
some fusions in senescent ﬁbroblasts with dysfunctional telomeres
demonstrated that these unprotected telomeres must be resistant
to fusion, leading to the proposal that they must continue to have
structures that prevent fusion despite being recognizable as DSBs
(Kaul et al., 2012). However, the analysis of individual telomeres
using single telomere end length analysis (STELA) demonstrated
that chromosome fusions can occur at a low frequency in dividing
human ﬁbroblasts, and therefore that some ﬁbroblasts containing
fusions are capable of continued cell division (Capper et al., 2007).
How these rare ﬁbroblasts in the population adapt or fail to detect
dysfunctional telomeres is not known.
The consequences of telomere shortening are dramatically dif-
ferent in cells with compromised cell cycle regulation. This was
ﬁrst demonstrated in human ﬁbroblasts in which the p16 and
p53 proteins in the senescence pathway were inactivated by viral
proteins (Counter et al., 1992). The failure of these ﬁbroblasts to
senescence results in continued telomere shortening beyond the
point that senescence would normally occur, eventually leading
to “crisis,” which involves extensive chromosome fusion and cell
death. However, rarely cells can survive crisis by acquiring the
ability to maintain telomeres through the reactivation of telom-
erase (Counter et al., 1992) or through activation of an alternative
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pathway (ALT; Murnane et al., 1994; Bryan et al., 1995) involving
recombination (Dunham et al., 2000), leading to the hypothe-
sis that telomere maintenance is necessary for the extended cell
division required for malignant cancer progression. Proof that
telomerase expression is capable of providing cells with an indeﬁ-
nite life spanwas subsequently provided by the prolonged life span
of human ﬁbroblasts transfected with the gene for the catalytic
subunit of telomerase, hTERT (Bodnar et al., 1998). A critical role
for telomere maintenance in cancer is now well documented by
the demonstration that nearly all malignant cancers have acquired
the ability to maintain telomeres, in most cases through the
expression of telomerase, although approximately 10% maintain
telomeres through the ALT pathway (Shay andWright, 2005). One
apparent exception is chronic lymphocytic leukemia, in which
telomere shortening continues to occur during disease progression
(Lin et al., 2010).
Despite the fact that ﬁbroblasts surviving crisis are capable of
maintaining telomeres, they typically have highly rearranged chro-
mosomes due to the extensive telomere shortening that occurred
prior to expression of telomerase or ALT (Counter et al., 1992;
Murnane et al., 1994). The structure of the chromosome fusions
occurring in ﬁbroblasts that fail to senesce has been extensively
analyzed using STELA (Capper et al., 2007; Letsolo et al., 2010).
The importance of the chromosome rearrangements caused by
this extensive telomere shortening in cancer was demonstrated in
mice that are deﬁcient in the RNA subunit of telomerase, mTERC,
and p53 (Artandi et al., 2000). Although mice with knockout
of mTERC alone show an increase in cancer, the presence of
mutations in p53, which allows for growth of cells with chromo-
some instability, accelerates carcinogenesis and shifts the spectrum
toward carcinomas. Moreover, the chromosomes in these carcino-
mas demonstrated rearrangements consistent with chromosome
instability resulting from telomere loss. These results demon-
strated that telomere loss in telomerase-deﬁcient cells lacking cell
cycle regulation results in chromosome rearrangements leading
to cancer. However, the cancers in these telomerase/p53-deﬁcient
mice were limited in that they did not occur in all tissues and
did not fully develop into highly malignant tumors. The limited
cancer phenotype in thesemice results from the lack of telomerase
activity, since Cre recombinase-mediated activation of telomerase
activity results in a more complete tumor spectrum and bone
metastases in these mice (Ding et al., 2012). These studies prove
that both chromosome instability resulting from telomere loss,
and the acquisition of the ability to actively maintain telomeres
are important events that contribute to carcinogenesis.
Based on the above observations, it is often assumed that chro-
mosome rearrangements resulting from telomere loss in cancer
cells is a result of the transient period of telomere loss occurring
during crisis before cancer cells acquire the ability tomaintain their
telomeres (Figure 1). However, it is now clear that not all chro-
mosome rearrangements resulting from telomere dysfunction in
cancer cells originate during crisis. Some cancers may arise in
which telomerase activation occurs prior to crisis. Moreover, can-
cer cells commonly continue to demonstrate telomere dysfunction
despite the expression of telomerase (see below). Although not as
frequent as the telomere loss occurring during crisis, this lower
rate of telomere loss is not lethal to the cell, and can therefore
result in extensive chromosome rearrangements that can continue
to occur throughout the lifetime of the tumor.
STOCHASTIC MECHANISMS OF TELOMERE LOSS
In addition to gradual telomere shortening during cell division, the
loss of telomere function can also occur as a result of stochastic
events in which large blocks of telomeric repeat sequences are lost
in a single rapid deletion event. Studies in yeast have demonstrated
that a variety of mechanisms can result in stochastic telomere loss
(Lustig, 2003). Stochastic telomere loss was initially described in
the ﬁrst report on the ability of human cells to maintain telom-
eres through the ALT pathway, which led to the prediction that
this pathway involves recombination (Murnane et al., 1994). The
correlation between the frequency of stochastic changes in telom-
ere length and the frequency of chromosome fusions in this cell
line also led to the conclusion that stochastic telomere loss was
a mechanism for chromosome instability. As mentioned above,
chromosome fusions resulting from stochastic telomere loss have
also been observed in primary human ﬁbroblasts, demonstrating
FIGURE 1 | Contribution of telomere loss to chromosome instability in
cancer. Oncogene expression causes unregulated cell division, resulting in
replication stress and excessive telomere shortening. The very short
telomeres or DSBs near telomeres that are caused by replication stress result
in cell senescence. Mutations in the p53 and p16 proteins that are required
for cell cycle regulation can allow cells to continue to divide, leading to cell
crisis as a result of dysfunctional telomeres and extensive chromosome
fusion. The activation of telomerase expression or the ALT pathway
in rare cells allows for continued cell division, although the surviving
cells will contain chromosome rearrangements as a result of telomere
loss during crisis. Cells expressing telomerase will continue to experience
a low rate of telomere loss due to a combination of replication stress
causing DSBs near telomeres and a deﬁciency in DSB repair in subtelomeric
regions.
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that some ﬁbroblasts in the population can continue to divide
despite the presence of chromosomes with dysfunctional telom-
eres (Capper et al., 2007). Stochastic events are also responsible for
thehigh rate of spontaneous telomere loss and chromosome fusion
that occur in many human cancer cells despite the expression of
telomerase. We ﬁrst reported a high rate of telomere instabil-
ity leading to chromosome fusions in the SQ9G squamous cell
carcinoma cell line (Sprung et al., 1999a) and the EJ-30 bladder
cell carcinoma cell line (Fouladi et al., 2000). Subsequent studies
have demonstrated that this high rate of spontaneous telomere
loss and chromosome fusion is common to many tumor cell lines
and early passage cancer cells (Gisselsson et al., 2001; Nakamura
et al., 2009). Thus, despite the expression of telomerase, telom-
ere loss can continue to contribute to chromosome instability in
cancer cells.
Errors occurring during DNA synthesis are likely to be an
important mechanism for stochastic telomere loss in cancer cells.
Telomeric DNA is a poor substrate for semi-conservative DNA
replication, because telomeric DNA consists of a guanine-rich
sequence on one strand and a cytosine-rich sequence on the other
strand. As a result, telomeric DNA can take on non-B form higher
order structures, such as G-quadruplexes. G-quadruplex DNA is
much more stable than the B form of double-stranded DNA, and
can pose a problem forDNA replication (Lipps andRhodes, 2009).
As a result, the 3′ to 5′ helicase activity ofWRN,BLM (Mohaghegh
et al., 2001), or RTEL1 (Ding et al., 2004) is required for replication
of G-quadruplex DNA in vitro. In mammalian cells, WRN inter-
acts with TRF2 and localizes at telomeres (Opresko et al., 2002).
Consistent with an essential role for WRN in telomere function,
WRN-deﬁcient cells show chromosome fusions on the lagging
strand, a DNA damage response, a growth defect, genome insta-
bility, and premature senescence. The expression of TERT and
telomere elongation rescues these defects in WRN-deﬁcient cells
(Crabbe et al., 2004).
In addition to G-quadruplex structures, the D-loop structure
created during t-loop formation also prevents replication fork pro-
gression, and resolution of the D-loop is required for telomere
replication. WRN (Opresko et al., 2004) and RTEL1 (Barber et al.,
2008) are also capable of resolving the D-loop structure. In addi-
tion to its helicase activity,WRN also possess a 3′ to 5′ exonuclease
activity, andboth activities cooperate to release the single-stranded
3′ invading overhang from the D-loop to permit the replication of
the t-loop structures at telomeres (Opresko et al., 2004).
The replication of telomeric DNA is facilitated by the shel-
terin proteins TRF1 and TRF2, which bind to double-stranded
telomeric DNA, and POT1, which binds to telomeric single-
stranded 3′ overhangs. These proteins facilitate the replication
of fork progression at telomeres by regulating the higher order
structure of telomeric DNA. TRF1 plays an essential role in
replication fork progression at telomeres, with the inhibition
of TRF1 resulting in an ATR-mediated DNA damage response,
chromosome breakage at telomeres, and chromosome instability
(Sfeir et al., 2009). TRF2 induces positive supercoiling and mod-
iﬁes the topology of telomeric DNA (Amiard et al., 2007). This
supercoiling-inducing activity of TRF2 is suggested to unwind
DNA outside of TRF2 complexes. TRF2 relieves topological stress
during telomere replication with the cooperation of Apollo and
Top2-α (Ye et al., 2010). In yeast, Taz1, the ortholog of TRF1
and TRF2, is also required for replication of telomeric sequences
(Miller et al., 2006). POT1 interacts with the telomeric single-
stranded 3′overhang and prevents the formation of G-quadruplex
structures (Zaug et al., 2005). POT1 also suppressesATR activation
at telomeres by blocking the binding of RPA to the single-stranded
3′ overhang (Denchi and de Lange, 2007). However, the sup-
pression of ATR at telomeres may also prevent the detection of
stalled replication forks, which could promote telomere loss and
chromosome instability.
Stalled replication forks at telomeres can result from the pres-
ence of DNA damage in telomeric repeat sequences. This is an
importantmechanism for telomere loss, because telomeric regions
are deﬁcient in DNA repair. Ultraviolet light-induced pyrimidine
dimers are poorly repaired at telomeres (Kruk et al., 1995). The
guanine triplets in telomeric repeat sequences are also especially
sensitive to oxidativemodiﬁcations resulting from oxidative stress,
and this oxidative damage at telomeres is also poorly repaired
(Oikawa et al., 2001; Rhee et al., 2010). Moreover, oxidative dam-
age causes the accumulation of single-strand breaks in G-rich
strands, and these single-strand breaks are poorly repaired and
persist longer at telomeres (Petersen et al., 1998). These oxida-
tive base-modiﬁcations or single-strand breaks pose problems
during DNA replication, as demonstrated by the telomere short-
ening and loss that occurs in cells undergoing oxidative stress
(von Zglinicki, 2002).
The challenges of replicating telomeric regions can also result
in the loss of telomeres under conditions of replication stress.
Replication forks pause at regions with altered chromatin con-
formations in yeast, including telomeres, and require the RRM3
helicase to progress through these regions (Ivessa et al., 2002). A
deﬁciency in RRM3 results in stalled replication forks in these
regions, which subsequently leads to DSBs. Similarly, in mam-
malian cells, some DNA sequences also pose problems for DNA
replication. The chromosome locations of these DNA sequences,
known as fragile sites, form DSBs under conditions of replica-
tion stress (Debatisse et al., 2012). The regions near telomeres in
mammalian cells have been demonstrated to be fragile sites in that
chemically induced replication stress results in telomere instabil-
ity (Sfeir et al., 2009). As a result, cellular alterations that affect the
efﬁciency of the DNA replication machinery can promote stalled
replication forks at telomeres and telomere loss.
THE ROLE OF STOCHASTIC TELOMERE LOSS IN
CHROMOSOME INSTABILITY IN CANCER
We investigated the role of stochastic telomere loss in chromosome
instability in human cancer using clones of the telomerase-
positive/p53-deﬁcient EJ-30 human tumor cell line (Fouladi et al.,
2000). These clones have the pNCT-tel plasmid containing the
Herpes Simplex virus thymidine kinase (HSV-tk) gene integrated
immediately adjacent to a telomere. Selection in ganciclovir for
the loss of function of the HSV-tk gene serves as a marker for
telomere loss on this chromosome. The rate of spontaneous loss
of the HSV-tk gene near the telomere was found to be 10−4
events/cell/generation, which wasmore than 100-fold greater than
at interstitial sites. In view of the fact that there are 96 telomeres,
this means that one telomere is lost in this cell line approximately
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every 100 cell divisions. Unlike the overwhelming loss of telomeres
occurring in crisis, the low frequency of telomere loss in cancer
cells expressing telomerase is not lethal, although it provides a
continued source of chromosome instability (Figure 1, see below).
We have proposed that this spontaneous telomere loss in
human cancer cells results from stalled replication forks at telom-
eres due to oncogene-induced replication stress (Murnane, 2010).
Oncogene expression has been demonstrated to result in replica-
tion stress (Halazonetis et al., 2008; Tsantoulis et al., 2008). The
importance of replication stress in genomic instability in cancer is
demonstrated by the prevalence of rearrangements at fragile sites
in human cancer cells (Bignell et al., 2010). Although chromosome
rearrangements can occur at any fragile site, the DSBs occurring
near telomeres would be especially vulnerable to chromosome
rearrangements due to a deﬁciency inNHEJ near telomeres (Miller
et al., 2011; Fumagalli et al., 2012; Hewitt et al., 2012). Consistent
with ourmodel for oncogene-induced replication stress as amech-
anism for telomere loss, oncogene expression has subsequently
been shown to result in telomere dysfunction-induced senescence
(TDIS) in normal human ﬁbroblasts in culture, and in vivo in pre-
neoplastic cells (Suramet al., 2012). The fact that the dysfunctional
telomeres in the cells with TDIS still contained telomeric repeat
sequences led the authors to conclude that irreparable DSBs near
telomeres rather than telomere loss were likely to be responsible.
In contrast, TDIS was not observed in malignant tumors. There-
fore, although oncogene-induced replication stress would result
in telomere loss in tumor cells, the lack of cell cycle checkpoints
would allow tumor cells with chromosomes without telomeres to
continue to grow, leading to chromosome instability.
MECHANISMS OF CHROMOSOME INSTABILITY RESULTING
FROM TELOMERE LOSS
Barbara McClintock ﬁrst proposed over seventy years ago that
telomere loss can result in chromosome fusion and instability
as a result of breakage-fusion-bridge (B/F/B) cycles (McClintock,
1941). B/F/B cycles occur when chromosome fusions resulting
from telomere loss produce chromosomes containing two cen-
tromeres. B/F/B cycles can occur either by fusion between two
different chromosomes, or fusion between sister chromatids fol-
lowing the replication of the chromosome without a telomere
(Murnane, 2006). The chromosome can form a bridge during
anaphase when the two centromeres are pulled in opposite direc-
tions, causing the chromosome to break as the cell divides. With
sister chromatid fusion, the chromosome breaks result in inverted
repeats on the end of the chromosome in one daughter cell and a
terminal deletion on the chromosome in the other daughter cell.
Because the broken chromosomes still do not have a telomere on
one end, following replication the sister chromatids can again fuse
and break in the next cell cycle. This cycle continues until the
chromosome is lost, the cell dies, or the chromosome acquires a
new telomere, which usually occurs by translocation of the end of
another chromosome (Artandi et al., 2000; Sabatier et al., 2005).
We have investigated the series of events involved in chro-
mosome instability resulting from spontaneous telomere loss
in clone B3 of the EJ-30 human tumor cell line in which the
pNCT-tel plasmid is located immediately adjacent to a telomere
on chromosome 16 (Fouladi et al., 2000; Lo et al., 2002a; Sabatier
et al., 2005). Unlike other studies, this approach allows us to
select for the loss of a single telomere, and thereby follow the
series of events involved in chromosome instability, rather than
attempting to reconstruct the consequences of telomere loss
based on rearrangements involving random chromosomes. The
results conﬁrm that spontaneous telomere loss results in chro-
mosome instability involving B/F/B cycles, and that these B/F/B
cycles continue for many cell generations. DNA sequence anal-
ysis of the recombination site in several ganciclovir-resistant
subclones demonstrated the presence of inverted repeats, indi-
cating that telomere loss resulted in sister chromatid fusion.
Evidence for B/F/B cycles involving sister chromatid fusions
was also provided by the absence of a telomere on the marker
chromosome 16 in many cells in the population after many
cell generations (Fouladi et al., 2000), as well as by ampliﬁca-
tion of subtelomeric DNA (the region adjacent to the telomere)
and anaphase bridges involving the marker chromosome 16
(Lo et al., 2002a).
The effect of B/F/B cycles on chromosomal instability in the
EJ-30 clone B3 was further investigated by analyzing the mecha-
nisms through which the marker chromosome 16 acquired a new
telomere (Sabatier et al., 2005). Cytogenetic analysis revealed that
after more than 20 cell generations, the marker chromosome 16
had acquired a new telomere in over 80%of the cells in the popula-
tion, and that over half of the new telomereswere acquired through
translocation of portions of other chromosomes. Almost a quar-
ter of all telomere acquisition occurred through non-reciprocal
translocations. These non-reciprocal translocations often resulted
in loss of a telomere from the donor chromosome, thereby trans-
ferring the instability to the donor chromosome, which could then
goon to acquire a new telomere froma third chromosome. Inother
cells in the population, themarker chromosome 16 had acquired a
new telomere by translocations involving duplications of the arms
of other chromosomes.While this does not result in chromosomal
instability being passed on to other chromosomes, it does lead to
allelic imbalance, which is associated with cancer progression
The above studies clearly demonstrate that B/F/B cycles result-
ing from telomere loss can generate many of the types of
chromosome rearrangements commonly associated with human
cancer. Evidence that B/F/B cycles are involved in human cancer
is shown by the prominence of inverted repeats within ampli-
ﬁed regions in human cancers (Ford and Fried, 1986; Guenthoer
et al., 2011), which have been proposed to result from B/F/B
cycles (Guenthoer et al., 2011). Cancer genome sequencing has
also shown that inverted repeats are common in pancreatic can-
cer, leading to the proposal that telomere loss and B/F/B cycles play
an important role in this disease (Campbell et al., 2010). Although
ampliﬁed regions in cancer cells are not always located at their
original locations, this does not exclude B/F/B cycles as a mech-
anism. Ampliﬁed regions containing inverted repeats are highly
unstable and can form double-minute chromosomes (Singer et al.,
2000) that can reintegrate at other locations (Windle et al., 1991;
Coquelle et al., 1998).
THE SENSITIVITY OF TELOMERIC REGIONS TO DSBs
To investigate the mechanisms of telomere loss in human can-
cer cells, we have analyzed the types of rearrangements resulting
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from DSBs near telomeres in clones of the EJ-30 human tumor
cell line that contain the pNCT-tel or pNTIL-tel plasmids with an
I-SceI site that are integrated at either interstitial or telomeric sites
(Zschenker et al., 2009). Consistent with earlier studies, we found
that small deletions are the most common mutation when DSBs
are induced at interstitial sites,while largedeletions andgross chro-
mosomal rearrangements (GCRs) are rarely observed (Figure 2).
A similar frequency of small deletionswas observedwhenDSBs are
generated near telomeres. However, unlike interstitial DSBs, large
deletions andGCRs are themost common type of DNA rearrange-
ments at DSBs near telomeres (Figure 2). These GCRs included
inverted repeats, translocations, and dicentric chromosomes, all
of which can lead to further chromosome rearrangements or loss.
These observations led us to be the ﬁrst to conclude that telom-
eric regions are highly sensitive to DSBs. In a subsequent study,
we demonstrated that the sensitivity of subtelomeric regions to
DSBs extends at least 100 kb from the telomere (Kulkarni et al.,
2010), and therefore subtelomeric regions represent a relatively
large target for DSB-induced chromosomal instability (Kulkarni
et al., 2010). An increased sensitivity to DSBs in telomeric regions
has also been observed in studies in yeast, and these DSBs were
found to be more likely to result in GCRs than DSBs at interstitial
sites (Ricchetti et al., 2003).
We next investigated the frequency of DSB repair at intersti-
tial and telomeric sites using clones of the EJ-30 tumor cell line
in which DSB repair is monitored by the activation of a gene for
green ﬂuorescent protein (Miller et al., 2011). No difference was
observed in HRR for telomeric and interstitial DSBs; however,
the frequency of NHEJ at telomeric DSBs was found to be much
lower than that observed at interstitialDSBs.Wehavehypothesized
(Miller et al., 2011) that this deﬁciency in NHEJ near telomeres
is due to cis-acting telomere-binding proteins whose presence at
telomeric regions causes DSBs to be processed as though they
were telomeres (Figure 3). Following DNA replication, the lead-
ing strand at the end of the chromosome must be resected to
generate a single-stranded 3′ overhang. This resection by either
Apollo or MRE11 is regulated by TRF2 (Zhu et al., 2000; Deng
et al., 2009; Lam et al., 2010; Wu et al., 2010), and is limited by
the binding of POT1/TPP1 to the single-stranded 3′ overhang
and formation of the t-loop. Our model proposes that TRF2
similarly directs the inappropriate resection of DSBs occurring
near telomeres; however, because the single-stranded ends that
are generated by resection are not composed of telomeric repeat
sequences, POT1/TPP1 cannot bind to limit resection. As a result,
excessive degradation occurs at the DSB. Although these large
single-stranded regions at the DSB could facilitate HRR during
G2 phase, they would inhibit C-NHEJ in other parts of the cell
cycle, leading to telomere loss and GCRs involving A-NHEJ.
Consistent with our results in human tumor cells, two recent
studies have reported that irreparable DSBs near telomeres in
mammalian cells contribute to aging and stress-induced senes-
cence (Fumagalli et al., 2012; Hewitt et al., 2012). Human cells
exposed to ionizing radiation in culture and mouse cells in vivo
demonstrate persistent DSB repair foci near telomeres, which
correlate with stress-induced senescence. Similarly, aging normal
tissues also accumulateDSB repair foci near telomeres. The ectopic
localization of TRF2 caused a delay in repair of interstitial DSBs
FIGURE 2 |The types of events resulting from interstitial and telomeric
I-SceI-induced DSBs. DSB repair at interstitial sites occurs primarily by
C-NHEJ, although some DSBs are also repaired by HRR, involving error-free
repair, and A-NHEJ, which is associated with large deletions and GCRs.
Direct ligation of the ends of DSBs without the loss of the I-SceI site by
C-NHEJ is the most common event at interstitial DSBs. Small deletions of a
few base pairs that eliminate the I-SceI site are the next most common
event, followed by HRR, large deletions, and GCRs. The deﬁciency in NHEJ
near telomeres is proposed to be due to inhibition of C-NHEJ, while the
efﬁciency of HRR is unchanged. As a result, most DSBs near telomeres are
repaired by A-NHEJ. Consistent with a predominant role for A-NHEJ in
repair of telomeric DSBs, large deletions are the most common event at
I-SceI-induced DSBs near telomeres. Most of these large deletions would
also result in GCRs, because they cause the loss of the telomere. GCRs
that occur without large deletions are also greatly increased at DSBs near
telomeres, while small deletions of a few base pairs occur at the same
frequency as at interstitial DSBs.
(Fumagalli et al., 2012), consistent with our model that TRF2 is
responsible for the inhibition of repair of DSBs near telomeres.
Moreover, this study demonstrated that the presence of telomeric
repeat sequences inhibited the recruitment of the NHEJ protein
LIG4 in yeast (Fumagalli et al., 2012), consistent with our results
demonstrating a deﬁciency in NHEJ near telomeres in human
tumor cells. Although not addressed in either study, the size
of the target can be estimated from the frequency of persistent
DSBs. The frequency of DSBs generated by X-rays is approxi-
mately 25–40 per Gy (Costes et al., 2010). These studies found
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FIGURE 3 | Model for processing DSBs near telomeres.The presence of
TRF2 at the telomere (red horizontal lines) promotes chromosome healing by
inhibiting ATM, which is required to activate PIF1 and/or other redundant
proteins that prevent chromosome healing by binding to TERT, the catalytic
subunit of telomerase. TRF2 also promotes the inappropriate processing of
DSBs near telomeres by Apollo, which is then followed by extensive
resection by EXO1. This function of Apollo is normally involved in the
generation of single-stranded 3′ overhangs required for telomere formation.
However, unlike telomeres (red horizontal lines), in which resection is limited
by POT1/TPP1 binding to the single-stranded telomeric DNA, resection of
DSBs in subtelomeric regions (black horizontal lines) continues unabated due
to the inability of POT1/TPP1 to bind to non-telomeric DNA. The inappropriate
processing of the DSB results in large deletions and/or GCRs with other
chromosomes (green horizontal lines) through a mechanism involving A-NHEJ.
approximately two to three persistent γH2AX foci after 20 Gy of
X-rays, which represents 0.25–0.6%of theDSBs initially generated
in these cells after 20 Gy. However, as was pointed out (Fumagalli
et al., 2012), a target composed of telomeric repeat sequences rep-
resents only approximately 0.02% of the total human genomic
DNA (12 kb average telomere length ×92 telomeres 6 × 109 bp
per genome = 0.018%). The target size that results in persis-
tent γH2AX foci is therefore 14–33 times larger (168–396 kb per
telomere) than the telomeric repeat sequences themselves, consis-
tent with our model that subtelomeric sequences are deﬁcient in
DSB repair.
CHROMOSOME HEALING IN RESPONSE TO DSBs
NEAR TELOMERES
We have also investigated the effect of DSBs near telomeres on
chromosome instability inmouse embryonic stem (ES) cells. As in
our studieswith the EJ-30 tumor cell line, these studies used I-SceI-
inducedDSBs andplasmids containing theHSV-tk gene integrated
immediately adjacent to a telomere (Sprung et al., 1999b; Lo et al.,
2002b; Gao et al., 2008; Reynolds et al., 2011). The results were
similar in many respects to those obtained with EJ-30, in that
two of the most common rearrangements resulting from DSBs
near telomeres are large deletions and sister chromatid fusions. In
addition, the sister chromatid fusions initiated B/F/B cycles, which
resulted in ampliﬁcation of subtelomeric regions and transloca-
tions, although the B/F/B cycles in mouse ES cells were much
shorter in duration than in human tumor cells. The presence of
B/F/B cycles in mouse ES cells is important in that it demon-
strated for the ﬁrst time that chromosome instability resulting
from telomere loss is not conﬁned to tumor cells. An impor-
tant difference we observed between mouse ES cells and the EJ-30
human tumor cell line is the prevalence of chromosome healing
in mouse ES cells, which involves the addition of a new telom-
ere at the site of the DSB. Chromosome healing accounted for
only approximately 1% of the total rearrangements resulting from
DSBsnear telomeres in theEJ-30 clones, but accounted for approx-
imately one-third of the rearrangements in mouse ES cells. Unlike
chromosome fusions, which primarily occurred following exten-
sive degradation at the site of theDSB, chromosome healing nearly
always occurred at the site of the DSB, and therefore prevented the
extensive degradation and chromosome instability resulting from
DSBs near telomeres. Because chromosome healing has not been
observed by us or others at I-SceI- or ionizing radiation-induced
DSBs at interstitial sites (Latre et al., 2004; Rebuzzini et al., 2005;
Varga and Aplan, 2005; Honma et al., 2007), we proposed that
chromosome healing in mouse ES cells serves as an important
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mechanism to compensate for the deﬁciency in DSB repair near
telomeres. We also proposed that the apparent deﬁciency in chro-
mosome healing in human tumor cells could contribute to the
chromosome instability resulting from spontaneous telomere loss
in human tumor cells.
Chromosome healing has been studied extensively in yeast,
although very little is known about the regulation of chromo-
some healing in mammalian cells. In yeast, chromosome healing
is inhibited by PIF1, and mutations in PIF1 result in a 1000-
fold increase in chromosome healing (Schulz and Zakian, 1994).
PIF1 mutations also result in telomere elongation, demonstrating
that PIF1 regulates telomerase. Consistent with this conclusion,
PIF1 binds to TERT, and mutations in TERT that inﬂuence PIF1
binding result in telomere elongation similar to cells deﬁcient in
PIF1 (Eugster et al., 2006). The inhibition of chromosome heal-
ing requires the phosphorylation of PIF1 by MEC1 in response to
DSBs (Makovets and Blackburn, 2009). This inhibition of PIF1 in
response to DSBs has been proposed as a mechanism for prevent-
ing PIF1 from interfering with DSB repair and causing terminal
deletions (Zhou et al., 2000).
The high frequency of chromosome healing in mouse ES cells
has allowed us to investigate the mechanism of chromosome
healing in mammalian cells. As in yeast, we demonstrated that
chromosome healing is performed by telomerase, although cells
that have acquired the ability to maintain telomeres through the
ALT pathway are also capable of performing chromosome heal-
ing (Gao et al., 2008). However, unlike yeast, the inhibition of
PIF1 had no effect on chromosome healing (Reynolds et al., 2011),
despite the fact that human PIF1 binds to TERT, as it does in yeast
(Mateyak and Zakian, 2006; Snow et al., 2007). Based on these
results, it has been proposed that the regulation of chromosome
healing is likely to be redundant in mammalian cells (Snow et al.,
2007; Reynolds et al., 2011). The prevalence of chromosome heal-
ing near telomeres could result from the inactivation of ATM by
TRF2 (Karlseder et al., 2004), since the activation of PIF1 and
other proteins for chromosome healing could require phospho-
rylation by ATM (Figure 2), similar to the activation by MEC1
in yeast. Although chromosome healing would result in terminal
deletions, the consequences would be relatively minor at DSBs
near telomeres, and preferable to chromosome instability result-
ing from telomere loss. Why human cancer cells are deﬁcient in
chromosomehealing near telomeres is not known, but could result
from excessive degradation of DSBs near telomeres in human can-
cer cells, since resection in yeast inhibits chromosome healing
(Chung et al., 2010; Lydeard et al., 2010).
THE IMPORTANCE OF TELOMERE LENGTH
IN HUMAN DISEASE
The length of telomeres at birth and the rate of telomere short-
ening in somatic cells can greatly inﬂuence the role of loss of
telomere function in human disease. The length of telomeres
at birth in humans can be affected by mutations in a variety
of proteins involved in telomere maintenance, either by affect-
ing telomere-capping function or by directly affecting telomere
elongation by telomerase. Deﬁnitive evidence that defects in
telomere maintenance are associated with human genetic disease
come from studies of the genetic disease Dyskeratosis Congenita,
which results in early death from bone marrow failure, pul-
monary complications, or malignancy (Mason and Bessler, 2011).
Dyskeratosis Congenita has now been shown to result frommuta-
tions in a number of different telomerase components, including
dyskerin, TERC, and TERT, as well as the shelterin component
TIN2, which result in telomere shortening and reduced prolifer-
ative capacity of cells. Genetic diseases other than Dyskeratosis
Congenita have now also been attributed to shortened telomeres,
some of which have phenotypes that overlap with Dyskeratosis
Congenita, including idiopathic pulmonary ﬁbrosis, Coats plus,
aplastic anemia, and liver disease (Savage and Bertuch, 2010;
Anderson et al., 2012; Armanios, 2012). Cardiovascular disease
has also correlated with telomere length, although the mechanism
involved has yet to be clearly established (Panayiotou et al., 2010;
Saliques et al., 2010).
In addition tomutations in proteins that affect telomere length,
human disease can also be inﬂuenced by factors that affect the rate
of telomere shortening after birth. An increased rate of telom-
ere shortening can result from either excessive division of adult
stem cells, which do not express sufﬁcient telomerase to com-
pensate for telomere loss during cell division. Alternatively, an
increased rate of telomere loss can also be caused by factors that
increase the amount of telomere loss during cell division, includ-
ing inﬂammation and oxidative stress (von Zglinicki, 2002). The
effect of life-style on telomere length was ﬁrst demonstrated by
the shortened telomeres in persons under stress (Epel et al., 2004).
Subsequent studies have found that a variety of life-style factors
can inﬂuence telomere length, including smoking, alcohol abuse,
and exercise (Lin et al., 2012).
TELOMERE LOSS AND GENETIC DISEASE
Our observation that DSBs near telomeres in mouse ES cells result
in telomere loss and chromosome instability has important impli-
cations for human evolution and genetic disease. Subtelomeric
regions in humans are highly dynamic, containing large numbers
of relatively recent duplications shared by different chromosomes,
leading to the proposal that subtelomeric regions serve as birth-
places for new genes (Mefford and Trask, 2002). The subsequent
analysis of these duplications led to the conclusion that they result
from a high frequency of translocations between subtelomeric
regions on different chromosomes (Linardopoulou et al., 2005).
This observation is consistent with the demonstration by our lab
and others that translocations are a commonmechanismof telom-
ere acquisition for chromosomes that have lost a telomere (Artandi
et al., 2000; Lo et al., 2002b; Sabatier et al., 2005). The sensitivity
of subtelomeric regions to DSBs is also consistent with the fact
that many human genetic diseases result from alterations near the
ends of chromosomes (Mefford and Trask, 2002), and that these
rearrangements are typical of the rearrangements that result from
telomere loss. Terminal deletions with telomeric repeat sequences
added directly on to the end of the broken chromosome, i.e., chro-
mosome healing, are responsible for a variety of genetic diseases
(Fortin et al., 2009; Bonaglia et al., 2011). In addition, terminal
deletions in combination with inverted repeats and transloca-
tions, classic hallmarks of telomere loss involving one or more
B/F/B cycles, are also known to result in numerous human genetic
diseases (Hoo et al., 1995; Cotter et al., 2001; South et al., 2006;
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Zuffardi et al., 2009; Yu andGraf, 2010). Understanding themech-
anisms responsible for the sensitivity of telomeric regions to DSBs
will therefore provide new insights into mechanisms of human
genetic disease, as well as aging (senescence) and cancer (genomic
instability).
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